Berberine and Cinnamon Synergy: A Promising Adjunct Therapy for Improving Glycemic Control and LDL Cholesterol in Type 2 Diabetes
Highlight
– Combined daily supplementation with 1200 mg berberine and 600 mg cinnamon for 12 weeks reduced fasting blood sugar (FBS) and HbA1c in type 2 diabetes patients.
– Significant reduction in low-density lipoprotein cholesterol (LDL-C) was observed, although total cholesterol, HDL-C, and triglycerides remained unchanged.
– No significant changes were found in other metabolic or anthropometric parameters, indicating targeted metabolic benefits.
– The combined regimen was well tolerated with no reported adverse safety concerns.
Study Background and Disease Burden
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.